For years, radical surgery was the only treatment for head and neck cancer (HNSCC).

For years, radical surgery was the only treatment for head and neck cancer (HNSCC).
Sudden sensorineural hearing loss (SSHL) has stumped otolaryngologists for decades.
Gene therapy as a treatment for cancer has advanced from the theoretical to the possible: in a pilot study published in August in the journal Science, investigators reported that two of 17 patients with advanced melanoma responded to a treatment known as genetically engineered therapy.
Continuous positive airway pressure (CPAP) is the standard first-line approach for moderate to severe obstructive sleep apnea.
Image-guided sinus (IGS) and skull base surgery is no longer considered experimental or investigational, and is appropriate for use by otolaryngologic surgeons to help clarify complex anatomy encountered during functional endoscopic sinus and skull base surgery (FESS).
A new Food and Drug Administration (FDA) advisory warns that the combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs) may result in life-threatening serotonin syndrome, which occurs when the body has too much serotonin.
What patient wouldn’t want three or four very small incisions that heal rapidly with little or no scarring and no residual numbness, compared with a foot-long slice at or under the hairline that takes longer to heal and sometimes leaves a puffed-up scar and/or permanent loss of sensation?